Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines.

Swanstrom JA, Nivarthi UK, Patel B, Delacruz MJ, Yount B, Widman DG, Durbin AP, Whitehead SS, De Silva AM, Baric RS.

J Infect Dis. 2019 Jun 19;220(2):219-227. doi: 10.1093/infdis/jiz109.

2.

Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model.

Nivarthi UK, Tu HA, Delacruz MJ, Swanstrom J, Patel B, Durbin AP, Whitehead SS, Pierce KK, Kirkpatrick BD, Baric RS, Nguyen N, Emerling DE, de Silva AM, Diehl SA.

EBioMedicine. 2019 Mar;41:465-478. doi: 10.1016/j.ebiom.2019.02.060. Epub 2019 Mar 8.

3.

Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.

Fowler AM, Tang WW, Young MP, Mamidi A, Viramontes KM, McCauley MD, Carlin AF, Schooley RT, Swanstrom J, Baric RS, Govero J, Diamond MS, Shresta S.

Cell Host Microbe. 2018 Nov 14;24(5):743-750.e5. doi: 10.1016/j.chom.2018.09.015.

PMID:
30439343
4.

Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate.

Swanstrom JA, Henein S, Plante JA, Yount BL, Widman DG, Gallichotte EN, Dean HJ, Osorio JE, Partidos CD, de Silva AM, Baric RS.

J Infect Dis. 2018 May 25;217(12):1932-1941. doi: 10.1093/infdis/jiy063.

5.

Congenital Zika virus infection as a silent pathology with loss of neurogenic output in the fetal brain.

Adams Waldorf KM, Nelson BR, Stencel-Baerenwald JE, Studholme C, Kapur RP, Armistead B, Walker CL, Merillat S, Vornhagen J, Tisoncik-Go J, Baldessari A, Coleman M, Dighe MK, Shaw DWW, Roby JA, Santana-Ufret V, Boldenow E, Li J, Gao X, Davis MA, Swanstrom JA, Jensen K, Widman DG, Baric RS, Medwid JT, Hanley KA, Ogle J, Gough GM, Lee W, English C, Durning WM, Thiel J, Gatenby C, Dewey EC, Fairgrieve MR, Hodge RD, Grant RF, Kuller L, Dobyns WB, Hevner RF, Gale M Jr, Rajagopal L.

Nat Med. 2018 Mar;24(3):368-374. doi: 10.1038/nm.4485. Epub 2018 Feb 5.

6.

Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4.

Widman DG, Young E, Nivarthi U, Swanstrom JA, Royal SR, Yount BL, Debbink K, Begley M, Marcet S, Durbin A, de Silva AM, Messer WB, Baric RS.

Sci Rep. 2017 Dec 7;7(1):17169. doi: 10.1038/s41598-017-17355-5.

7.

Permissivity of Dipeptidyl Peptidase 4 Orthologs to Middle East Respiratory Syndrome Coronavirus Is Governed by Glycosylation and Other Complex Determinants.

Peck KM, Scobey T, Swanstrom J, Jensen KL, Burch CL, Baric RS, Heise MT.

J Virol. 2017 Sep 12;91(19). pii: e00534-17. doi: 10.1128/JVI.00534-17. Print 2017 Oct 1.

8.

A Reverse Genetics Platform That Spans the Zika Virus Family Tree.

Widman DG, Young E, Yount BL, Plante KS, Gallichotte EN, Carbaugh DL, Peck KM, Plante J, Swanstrom J, Heise MT, Lazear HM, Baric RS.

MBio. 2017 Mar 7;8(2). pii: e02014-16. doi: 10.1128/mBio.02014-16.

9.

Dissecting Antibodies Induced by a Chimeric Yellow Fever-Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals.

Henein S, Swanstrom J, Byers AM, Moser JM, Shaik SF, Bonaparte M, Jackson N, Guy B, Baric R, de Silva AM.

J Infect Dis. 2017 Feb 1;215(3):351-358. doi: 10.1093/infdis/jiw576.

10.

Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.

Swanstrom JA, Plante JA, Plante KS, Young EF, McGowan E, Gallichotte EN, Widman DG, Heise MT, de Silva AM, Baric RS.

MBio. 2016 Jul 19;7(4). pii: e01123-16. doi: 10.1128/mBio.01123-16.

11.

SARS-like WIV1-CoV poised for human emergence.

Menachery VD, Yount BL Jr, Sims AC, Debbink K, Agnihothram SS, Gralinski LE, Graham RL, Scobey T, Plante JA, Royal SR, Swanstrom J, Sheahan TP, Pickles RJ, Corti D, Randell SH, Lanzavecchia A, Marasco WA, Baric RS.

Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3048-53. doi: 10.1073/pnas.1517719113. Epub 2016 Mar 14.

12.

Serum Immunoglobulin A Cross-Strain Blockade of Human Noroviruses.

Lindesmith LC, Beltramello M, Swanstrom J, Jones TA, Corti D, Lanzavecchia A, Baric RS.

Open Forum Infect Dis. 2015 Jul 1;2(3):ofv084. doi: 10.1093/ofid/ofv084. eCollection 2015 Sep.

13.

Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.

Lindesmith LC, Ferris MT, Mullan CW, Ferreira J, Debbink K, Swanstrom J, Richardson C, Goodwin RR, Baehner F, Mendelman PM, Bargatze RF, Baric RS.

PLoS Med. 2015 Mar 24;12(3):e1001807. doi: 10.1371/journal.pmed.1001807. eCollection 2015 Mar.

14.

Secondary contact seeds phenotypic novelty in cichlid fishes.

Nichols P, Genner MJ, van Oosterhout C, Smith A, Parsons P, Sungani H, Swanstrom J, Joyce DA.

Proc Biol Sci. 2015 Jan 7;282(1798):20142272. doi: 10.1098/rspb.2014.2272.

15.

Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.

Lindesmith LC, Donaldson EF, Beltramello M, Pintus S, Corti D, Swanstrom J, Debbink K, Jones TA, Lanzavecchia A, Baric RS.

J Virol. 2014 Aug;88(16):8826-42. doi: 10.1128/JVI.01192-14. Epub 2014 May 28.

16.

Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.

Debbink K, Lindesmith LC, Donaldson EF, Swanstrom J, Baric RS.

J Virol. 2014 Jul;88(13):7256-66. doi: 10.1128/JVI.00785-14. Epub 2014 Apr 16.

17.

Within-host evolution results in antigenically distinct GII.4 noroviruses.

Debbink K, Lindesmith LC, Ferris MT, Swanstrom J, Beltramello M, Corti D, Lanzavecchia A, Baric RS.

J Virol. 2014 Jul;88(13):7244-55. doi: 10.1128/JVI.00203-14. Epub 2014 Mar 19.

18.

Human norovirus detection and production, quantification, and storage of virus-like particles.

Debbink K, Costantini V, Swanstrom J, Agnihothram S, Vinjé J, Baric R, Lindesmith L.

Curr Protoc Microbiol. 2013 Nov 5;31:15K.1.1-15K.1.45. doi: 10.1002/9780471729259.mc15k01s31.

19.

Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects.

Swanstrom J, Lindesmith LC, Donaldson EF, Yount B, Baric RS.

J Virol. 2014 Jan;88(2):829-37. doi: 10.1128/JVI.02793-13. Epub 2013 Oct 30.

20.

Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus.

Scobey T, Yount BL, Sims AC, Donaldson EF, Agnihothram SS, Menachery VD, Graham RL, Swanstrom J, Bove PF, Kim JD, Grego S, Randell SH, Baric RS.

Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16157-62. doi: 10.1073/pnas.1311542110. Epub 2013 Sep 16.

21.

Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.

Debbink K, Lindesmith LC, Donaldson EF, Costantini V, Beltramello M, Corti D, Swanstrom J, Lanzavecchia A, Vinjé J, Baric RS.

J Infect Dis. 2013 Dec 1;208(11):1877-87. doi: 10.1093/infdis/jit370. Epub 2013 Aug 1.

22.

Taxonomic classification of phytoplankton with multivariate optical computing, part III: demonstration.

Pearl MR, Swanstrom JA, Bruckman LS, Richardson TL, Shaw TJ, Sosik HM, Myrick ML.

Appl Spectrosc. 2013 Jun;67(6):640-7. doi: 10.1366/12-06785.

PMID:
23735249
23.

Taxonomic classification of phytoplankton with multivariate optical computing, part II: design and experimental protocol of a shipboard fluorescence imaging photometer.

Swanstrom JA, Bruckman LS, Pearl MR, Abernathy E, Richardson TL, Shaw TJ, Myrick ML.

Appl Spectrosc. 2013 Jun;67(6):630-9. doi: 10.1366/12-06784.

PMID:
23735248
24.

Taxonomic classification of phytoplankton with multivariate optical computing, part I: design and theoretical performance of multivariate optical elements.

Swanstrom JA, Bruckman LS, Pearl MR, Simcock MN, Donaldson KA, Richardson TL, Shaw TJ, Myrick ML.

Appl Spectrosc. 2013 Jun;67(6):620-9. doi: 10.1366/12-06783.

PMID:
23735247
25.

Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes.

Lindesmith LC, Costantini V, Swanstrom J, Debbink K, Donaldson EF, Vinjé J, Baric RS.

J Virol. 2013 Mar;87(5):2803-13. doi: 10.1128/JVI.03106-12. Epub 2012 Dec 26.

26.

Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.

Lindesmith LC, Beltramello M, Donaldson EF, Corti D, Swanstrom J, Debbink K, Lanzavecchia A, Baric RS.

PLoS Pathog. 2012;8(5):e1002705. doi: 10.1371/journal.ppat.1002705. Epub 2012 May 17.

27.

Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.

Lindesmith LC, Debbink K, Swanstrom J, Vinjé J, Costantini V, Baric RS, Donaldson EF.

J Virol. 2012 Jan;86(2):873-83. doi: 10.1128/JVI.06200-11. Epub 2011 Nov 16.

Supplemental Content

Loading ...
Support Center